OR WAIT null SECS
May 16, 2019
WHP has been awarded with the design contract for the United Kingdom’s first dedicated vaccines manufacturing innovation center (VMIC).
A “Darwinian” drug discovery program aimed at tackling cancer’s ability to develop drug resistance will launch in a new center based in London, United Kingdom.
A CPhI Middle East & Africa (MEA) expert has forecasted a boom in manufacturing in the region and has expectations that within five years some of the industry will be acting as contract manufacturers for the European market.
The Association of the British Pharmaceutical Industry has issued a response to the recently aired BBC Radio 4 investigation program on opioids.
Locate Bio has been granted additional investment to the tune of £2 million (US$2.6 million) for the expansion of its cell and gene therapy pipeline.
The European Medicines Agency has issued a vacancy notice for the position of executive director.
The partnership will focus on the commercialization of inducible promoters to improve biomanufacturing.
May 10, 2019
The UK government announced during the ABPI’s recent conference that it is making improvements to the Accelerated Access Collaborative.
A UK-based company, Atelerix, has revealed that it has closed a second round of funding worth £700,000 (US$911,000).
Shakespeare Martineau, a law firm, announced that advisers from the firm have assisted Bermele with a capital-raising move worth £1 million (US $1.3 million).